The big biotech projects strong growth through 2020, but much of its …
Celgene
Buz Investors CELG Stock Bullish I have had my eye on Celgene Corporation(NASDAQ:CELG) stock and the price action on the CELG stock chart continues to suggest that something is brewing. The Celgene stock
Stock
Celgene Corporation (NASDAQ: CELG) is a biopharmaceutical company that researches and develops drugs for treating inflammatory diseases and various types of cancer. Celgene's core drugs are Revlimid, which makes …
Risk
CELG) has been assigned a $130.00 price target by Mizuho in a research note issued to investors on Sunday. The brokerage presently has a “buy” rating on the biopharmaceutical company’s stock. Mizuho’s price target …
BNS1mon
Target Corporation
Celgene Corporation is having an incredibly strong start to the trading week today. While the stock started off today's trading session on a business-as-usual note, things changed minutes ago as the stock skyrocketed …
Celgene
CELG plotted in green): Below is a three month price history chart comparing the stock performance of BMY vs. CELG: Another reason market capitalization is important is where it places a company in terms of its size tier …
market capitalization
Celgene Corporation (NASDAQ:CELG) announced that its phase III SUNBEAM trial, evaluating the efficacy …
NASDAQ
Celgene Corporation (CELG - Free Report) is scheduled to report fourth-quarter 2016 results on Jan 26, before the opening bell. Last quarter, the company reported a positive earnings surprise of 6.11%. Notably, shares of …
ZACKS2mon
Earnings
Nomura Securities analyst M. Ian Somaiya has reiterated a Buy rating for Celgene Corporation (NASDAQ:CELG) today, and raised the target price from $135 to $150. Regarding his view on the Summit, New Jersey based …
Investors in Celgene Corp. (NASD: CELG) saw new options become available today, for the February 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CELG options …